Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1592U89 (Abacavir) in NRTI-Experienced Patients
NCT00002364Phase 2Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abacavir in human immunodeficiency virus infection (HIV), sponsored by GSK. Status: completed.
02
Drugs
abacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002364.